UCF Researchers Discover Alzheimer's Movement Symptoms May Originate Outside the Brain
Key Takeaways
- ▸Alzheimer's-related movement problems can arise from mutations affecting the peripheral nervous system independent of brain involvement, demonstrated using human-on-a-chip technology
- ▸Motor deficits may serve as an earlier biomarker for Alzheimer's disease, potentially enabling earlier intervention before cognitive symptoms develop
- ▸Current brain-focused treatment approaches may be insufficient to address movement-related symptoms that originate outside the central nervous system
Summary
Researchers at the University of Central Florida, led by Professor James Hickman and Research Professor Xiufang Guo in collaboration with health care tech company Hesperos, have discovered that some movement-related symptoms of Alzheimer's disease may originate in the peripheral nervous system rather than the brain itself. Using innovative "human-on-a-chip" technology that recreates the neuromuscular junction in miniature lab systems, the team found that genetic mutations associated with familial Alzheimer's can disrupt motor neurons and the nerve-to-muscle connection independently of brain involvement. The findings, published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, suggest that movement deficits could be an earlier indicator of Alzheimer's disease, potentially years before cognitive symptoms appear. This discovery could fundamentally change how Alzheimer's is diagnosed and treated, as drugs targeting only the brain may not address movement problems originating in the peripheral nervous system.
- The study used lab-grown human cell systems to model familial Alzheimer's, providing a more realistic disease model than traditional approaches
Editorial Opinion
This research represents a significant paradigm shift in Alzheimer's understanding, suggesting that peripheral nervous system involvement deserves equal attention to central nervous system pathology. The use of human-on-a-chip technology demonstrates the transformative potential of organ-model systems in revealing disease mechanisms that traditional approaches might miss. If motor deficits prove to be a reliable early biomarker, the implications for patient diagnosis and intervention timing could be substantial, though further validation across broader populations will be essential.



